Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges
Timeline and outcomes of viral and fungal infections after chimeric antigen receptor T-cell therapy: a large database analysis
The market for chimeric antigen receptor T cell therapies
“Off-The-Shelf” allogeneic chimeric antigen receptor T-cell therapy for B-cell malignancies: current clinical evidence and challenges